# Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss

> **NCT02038972** · PHASE1,PHASE2 · COMPLETED · sponsor: **James Baumgartner, MD** · enrollment: 11 (actual)

## Conditions studied

- Sensorineural Hearing Loss

## Interventions

- **GENETIC:** Autologous Stem Cells

## Key facts

- **NCT ID:** NCT02038972
- **Lead sponsor:** James Baumgartner, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2015-12-11
- **Final completion:** 2017-01-10
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2018-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02038972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02038972, "Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02038972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*